Axsome Therapeutics (AXSM)
Developer of CNS medicines for depression, Alzheimer’s agitation, daytime sleepiness, and migraine.
$194.50
vs last close−8.60 (−4.23%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 40 days
EPS estimate
−$0.49
Revenue estimate
$258.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.54−$1.22−$0.92−$0.94−$0.71−$1.26−$0.99Pending
Estimate−$1.00−$1.26−$1.00−$0.82−$0.70−$0.85−$0.89−$0.49
Surprise−54.0%+3.2%+8.0%−14.6%−1.4%−48.2%−11.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$118.8M$121.5M$150.0M$171.0M$194.7M$189.4M$216.4MPending
Estimate$118.1M$119.2M$140.0M$191.3M$193.4M$190.9M$221.1M$258.3M
Surprise+0.6%+1.9%+7.2%−10.6%+0.7%−0.8%−2.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $4.62 | — | — |
| Sep 2028 | $3.50 | — | — |
| Jun 2028 | $2.88 | — | — |
| Mar 2028 | $2.42 | — | — |
| Dec 2027 | $1.63 | — | — |
| Sep 2027 | $1.09 | — | — |
| Jun 2027 | $0.56 | — | — |
| Mar 2027 | $0.02 | — | — |
| Dec 2026 | $0.08 | — | — |
| Nov 2026 | −$0.49 | — | — |
| Aug 2026 | −$0.89 | −$0.99 | −11.0% |
| May 2026 | −$0.85 | −$1.26 | −48.2% |
| Feb 2026 | −$0.70 | −$0.71 | −1.4% |
| Nov 2025 | −$0.82 | −$0.94 | −14.6% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Sep 2015 | |||
| Nov 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $4.62 | — | — | $729.0M | — | — | — |
| Sep 2028 | $3.50 | — | — | $544.5M | — | — | — |
| Jun 2028 | $2.88 | — | — | $447.4M | — | — | — |
| Mar 2028 | $2.42 | — | — | $374.5M | — | — | — |
| Dec 2027 | $1.63 | — | — | $453.2M | — | — | — |
| Sep 2027 | $1.09 | — | — | $396.3M | — | — | — |
| Jun 2027 | $0.56 | — | — | $346.2M | — | — | — |
| Mar 2027 | $0.02 | — | — | $296.4M | — | — | — |
| Dec 2026 | $0.08 | — | — | $298.5M | — | — | — |
| Nov 2, 2026 | −$0.49 | — | — | $258.3M | — | — | — |
| Aug 10, 2026 | −$0.89 | −$0.99 | −11.0% | $221.1M | $216.4M | −2.2% | +3.8% |
| May 4, 2026 | −$0.85 | −$1.26 | −48.2% | $190.9M | $189.4M | −0.8% | +8.3% |
| Feb 23, 2026 | −$0.70 | −$0.71 | −1.4% | $193.4M | $194.7M | +0.7% | −4.9% |
| Nov 3, 2025 | −$0.82 | −$0.94 | −14.6% | $191.3M | $171.0M | −10.6% | +0.6% |
| Aug 4, 2025 | |||||||
| May 5, 2025 | |||||||
| Feb 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 6, 2024 | |||||||
| Feb 20, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 2, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 8, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 14, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 7, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 11, 2016 | |||||||
| Mar 24, 2016 | |||||||
| Sep 30, 2015 | |||||||
| Nov 24, 2015 |